Climara Pro cleared for postmenopausal osteoporosis

01/10/2006 | (India)

The FDA has given its approval to a hormone therapy patch for preventing postmenopausal osteoporosis, an added indication for Climara Pro, which already has approval for treating hot flashes and night sweats. Schering said the patch allows the delivery of the hormone estradiol combined with levonorgestrel over a period of a week.

View Full Article in: (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President, Science and Regulatory Affairs
American Beverage Association
Washington, DC
Senior Manager of Medical Management
Network Health
Medford, MA
Columbus, OH
Manager, Medical Management
Network Health
Medford, MA
Executive Medical Director
Aspirus Network Inc
Wausau, WI